欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/0507/001
药品名称Invivac 2005/2006
活性成分
    • A/New Caledonia/20/99/ (H1N1) 30.0 µg/ml
    • A/Panama/2007/99 RESVIR-17 reass. (H3N2) 30.0 µg/ml
    • B/Yamanashi/166/98 30.0 µg/ml
剂型Solution for injection
上市许可持有人Solvay Pharmaceuticals BV C.J. van Houtenlaan 36 1381 CP Weesp The Netherlands
参考成员国 - 产品名称Netherlands (NL)
互认成员国 - 产品名称
    • Germany (DE)
    • Denmark (DK)
    • Belgium (BE)
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      Invivac Injektionssuspension
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
许可日期2004/06/10
最近更新日期2012/08/20
药物ATC编码
    • J07BB02 influenza, inactivated, split virus or surface antigen
申请类型
  • TypeLevel1：New Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Full Dossier Article 4.8 Di 65/65
  • TypeLevel4：Biological: Vaccine
  • TypeLevel5：Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase